Alnylam Pharmace. buy Chardan Capital
Summary
This prediction ended on 09.08.24 with a price of €247.10. With a performance of 46.56% the BUY prediction by Chardan_Capital was a big success. Chardan_Capital has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. Chardan_Capital has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Alnylam Pharmace. | 0.919% | 0.919% | 44.178% |
iShares Core DAX® | 1.743% | 1.903% | 18.038% |
iShares Nasdaq 100 | -2.088% | -0.640% | 25.594% |
iShares Nikkei 225® | 1.306% | 4.161% | 16.556% |
iShares S&P 500 | -0.093% | 0.169% | 24.312% |
Comments by Chardan_Capital for this prediction
In the thread Alnylam Pharmace. diskutieren
In the thread Trading Alnylam Pharmace.
Current prediction by Chardan_Capital for Alnylam Pharmace.
Alnylam Pharmace.
16.02.24
16.02.25
28.08.24